Oligomerisation of G-protein-coupled receptors.
暂无分享,去创建一个
[1] B. Bettler,et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. , 1997, Nature.
[2] A. Cornea,et al. Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.
[3] H. Akil,et al. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.
[4] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[6] G. Köhr,et al. Role of heteromer formation in GABAB receptor function. , 1999, Science.
[7] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[8] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[9] C. Martínez-A,et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Morrison,et al. Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[11] P. Vallotton,et al. Fluorescence techniques: shedding light on ligand-receptor interactions. , 2000, Trends in pharmacological sciences.
[12] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[13] J. Fritschy,et al. GABAB receptors make it to the top--as dimers. , 1999, Trends in pharmacological sciences.
[14] T. Gudermann,et al. Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors* , 2000, The Journal of Biological Chemistry.
[15] S. Nakanishi,et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.
[16] K. Ray,et al. Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization* , 2000, The Journal of Biological Chemistry.
[17] Kenneth A. Jones,et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.
[18] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[19] C. Martínez-A,et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[21] G. Milligan. New Aspects of G-Protein-Coupled Receptor Signalling and Regulation , 1998, Trends in Endocrinology & Metabolism.
[22] S. Russek,et al. Molecular Identification of the Human GABABR2: Cell Surface Expression and Coupling to Adenylyl Cyclase in the Absence of GABABR1 , 1999, Molecular and Cellular Neuroscience.
[23] R. Lefkowitz,et al. Heptahelical Receptor Signaling: Beyond the G Protein Paradigm , 1999, The Journal of cell biology.
[24] J. Wess,et al. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.
[25] S. Nakanishi,et al. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. , 2000, The Journal of biological chemistry.
[26] T. Gudermann,et al. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. , 1997, Molecular endocrinology.
[27] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[29] R Levenson,et al. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.
[30] Urs Gerber,et al. G-protein-independent signaling by G-protein-coupled receptors , 2000, Trends in Neurosciences.
[31] M. Scarselli,et al. Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments. , 2000, European journal of pharmacology.
[32] Christopher A Reynolds,et al. Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.
[33] G. Wallukat,et al. From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists. , 2000, Molecular pharmacology.
[34] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[35] C. Romano,et al. Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.
[36] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[37] Jilly F. Evans,et al. Identification of a GABAB Receptor Subunit, gb2, Required for Functional GABAB Receptor Activity* , 1999, The Journal of Biological Chemistry.
[38] J. Chambers,et al. Orphan G‐protein‐coupled receptors: the next generation of drug targets? , 1998, British journal of pharmacology.
[39] E I Canela,et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] Michel Bouvier,et al. Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.
[41] M. Bouvier,et al. Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. , 1998, The Biochemical journal.
[42] S. Angers,et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. , 2000, The Journal of clinical investigation.
[43] C. Martínez-A,et al. The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[45] D. Jenness,et al. Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. , 2000, Molecular biology of the cell.
[46] F. Marshall,et al. GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.
[47] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[48] S. Mennerick,et al. Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. , 2001, Molecular pharmacology.
[49] C. Forehand. A Peptide. , 1992, Science.
[50] G. Milligan. Receptors as Kissing Cousins , 2000, Science.
[51] R. Heim,et al. Using GFP in FRET-based applications. , 1999, Trends in cell biology.
[52] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[53] J. Wess,et al. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.
[54] N. Prévost,et al. Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.
[55] Pierre Corvol,et al. Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.
[56] M. Bouvier,et al. Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human δ Opioid Receptor* , 2000, The Journal of Biological Chemistry.
[57] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[58] T. Asano,et al. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells 1 , 1997, FEBS letters.
[59] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[60] U. Kumar,et al. Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.
[61] J. Wess,et al. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.
[62] H. Lother,et al. Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.
[63] Michel Bouvier,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .
[64] A Minarini,et al. Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. , 1998, European journal of pharmacology.
[65] G. Corsini,et al. Functional Role of the Third Cytoplasmic Loop in Muscarinic Receptor Dimerization* , 1996, The Journal of Biological Chemistry.
[66] Y. Jan,et al. A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.